A TECHNO-ECONOMIC NEWS MAGAZINE FOR MEDICAL PLASTICS AND PHARMACEUTICAL INDUSTRY
Our 15th Year of Publication
Page  1 of 1

Vision

Indian Medical Device Industry and Related Regulations
Rajiv Nath, President, AISNMA
 

VISION STATEMENT
  • INDIA TO BE AMONG THE "TOP 5" PREFFERED SOURCES IN EACH PRODUCT FAMILY OF MEDICAL DEVICES

  • INDIAN MEDICAL DEVICE REGULATORY AUTHORITY, A CENTRE FOR EXCELLENCE, ASSISTING THE MEDICAL DEVICE INDUSTRY TO PRODUCE PRODUCTS WITH ADEQUATE AND APPROPRIATE CONTROLS AND SYSTEMS FOR ENSURING PATIENT SAFETY

Current Status - Regulations
  • 18-20 Medical Devices under Drugs & Cosmetics Act 1940

  • Treatment similar to Drugs/Medicines

  • Controlled & Inspected by

  • Drug Controller General India/CDSCO

  • State Drug Controller

  • Central/ State Laboratories

  • License Raj ,undergoing review

  • Limited Knowledge/Competencies

  • Inspections, not standardized audits

  • Lack of acceptance of Risk based Assessment

  • New products/Technologies - Non existent product Standards

VISION - Role of the Industry
  • Accountable to the Public through a Regulator

  • Well run & managed

  • Meet the legal obligations

  • Delivery of Affordable low cost products

Current Status - Industry
  • Majority Exporting units comply with ISO13485 and Certificate/Registration with GHTF countries

  • Moving up the Value Chain

  • Moving up the Quality & Technology Ladder

  • "Top 5" Preferred Source Status achieved in: p

1) Syringes
2) Needles
3) I.V. Cannulas /Catheters
4) Contraceptives
5) Surgical Blades
6) Gloves

VISION - Role of Regulator
  • Work with Industry in transparent manner

  • Supervise Directly Through Accredited agencies

  • Aim to promote public trust in Indian Industry

  • Provide Guidance & Advice

- to meet legal obligations
- safety of consumers

  • Facilitate the Growth of Industry

  • Facilitate Introduction of Innovative & Emerging Technologies

SWOT ANALYSIS - Industry
 

Strengths

Cost Competitiveness, Mass production, Economies of scale, Trainable large Labor Pool, Technology Access - no conflicting national interest. Strong in Mechanical, Software, Biotechnology Engineering Respect for System & Document compliance.

Weakness

Low R&D base, Reliance on High Cost imported inputs.

High Cost Multiple Taxes. Limited products regulated.

Quality perception low middle end low- end.

Opportunity

Value for money competitiveness, high growth sales in global markets.

Threat

Regulations limiting market access if used as Protectionist Non Tariff Barrier

SWOT ANALYSIS - Regulator

Strengths

Reliance on Factory Inspections for domestic producers
Access to pool of inspectors well versed with GMP w.r.t. Pharmaceutical Industry, Strong legal framework

Weakness

Limited/no knowledge of diverse nature of manufacturing technologies
Limited knowledge of regulating non sterile medical devices
Regulatory framework not developed , structured for medical devices
Lack of accredited Testing facilities for product conformity verification
No inspections for overseas manufacturers,
lacks transparency & guidance

Opportunities

Up gradation of Regulatory framework on GHTF guidelines
Facilitate Respect & Growth Of Indian industry

Threats

Non manufacturer Devices from Regulated may harm patients
Non Recognition by overseas regulators

If Things go wrong.......

  • Regulations to provide non ambiguous legal requirements & guidance on best practices

  • Reliance on preventing problems

  • Evaluation of Risk & Hazard by MDR for suitable corrective action & preventive (CAPA)

  • Reasonable time for addressing issues and implementing CAPA

  • Regulator to have powers for putting things right

  • Minimal/No reliance of judiciary and legal criminal action on registered units

  • Reliance of Judiciary/ Police and criminal action only on non registered units.

Path for the Industry
  • Upgrade:

- manufacturing & testing facilities
- management competencies
- quality management systems

  • Get ISO 13485 certification from internationally accredited organizations
  • Get registration and certification from a GHTF member country
  • Self regulation/Dialog with MOH to assist in building regulatory framework
Pitfalls & Avoidance
  • Lack of trust and dialog

  • Lack of time bound response to queries

  • Reliance on Tests, inspections, arbitrary controls

  • Draconian punitive action

  • Unreasonable expectations

  • Lack of clarity of superseded rules/requirements and standards

  • Conformity assessment organizations acting as consultants / trainers to same assesses

Path for the Regulator

  • Improve transparency & dialog

  • Involve Industry in creating a mutually acceptable Regulatory Framework & Infrastructure.

  • Ensure timely response to guidance/ advice sought on clarifications of compliances

  • Constitute expert committees on various aspects

  • Define milestones for phased creation of a regulatory infrastructure & implementation p

  • Recognize risk based classification of devices and need for variation in regulatory controls, premarket registration & approvals proportionate to these risks.

  • Delegate supervision of conformity assessment to internationally accredited organizations with proven competencies

 
Back | Back to Top |Previous